Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05773443 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ANeED Joint Effort 21: eHealth and a PPI Program in Dementia With Lewybodies (DLB)

Study acronym: JointEffort21
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
University of Bergen
26 trials monitored
See 1 trial at risk
Dementia
1,978 trials monitored
See 106 trials at risk
The goal of the study is to develop predictive algorithms and digital biomarkers to capture disease fluctuations in (prodromal) dementia with lewybodies (DLB) patients and to improve treatment, diagnosis and prognosis of the study drug Ambroxol, used in the ANeED study. This project is an additional study to the ANeED study, registered at ClinicalTrials.gov under NCT04588285.
Trial Details
NCT Number NCT05773443
Lead Sponsor University of Bergen
Collaborators: Helse Fonna, Helse Stavanger HF, University Hospital, Akershus, Ullevaal University Hospital, Haraldsplass Deaconess Hospital, St. Olavs Hospital
Conditions
(from sponsor)		 Dementia, Lewy Body
Related terms Dementia, Lewy Body Disease
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov